BioGaia AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 50.15%

BioGaia AB (publ) (BIOG-B) has an Asset Resilience Ratio of 50.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BioGaia AB (publ) current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr801.31 Million

≈ $86.23 Million USD Cash + Short-term Investments

Total Assets

Skr1.60 Billion

≈ $171.95 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how BioGaia AB (publ)'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BIOG-B current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down BioGaia AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of BioGaia AB (publ) to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr801.31 Million	50.15%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr801.31 Million	50.15%

Asset Resilience Insights

Very High Liquidity: BioGaia AB (publ) maintains exceptional liquid asset reserves at 50.15% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

BioGaia AB (publ) Industry Peers by Asset Resilience Ratio

Compare BioGaia AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for BioGaia AB (publ) (2006–2025)

The table below shows the annual Asset Resilience Ratio data for BioGaia AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	50.15%	Skr801.31 Million ≈ $86.23 Million	Skr1.60 Billion ≈ $171.95 Million	-10.03pp
2024-12-31	60.18%	Skr1.22 Billion ≈ $131.72 Million	Skr2.03 Billion ≈ $218.89 Million	-5.96pp
2023-12-31	66.14%	Skr1.54 Billion ≈ $166.18 Million	Skr2.33 Billion ≈ $251.27 Million	-1.09pp
2022-12-31	67.23%	Skr1.49 Billion ≈ $160.17 Million	Skr2.21 Billion ≈ $238.26 Million	-2.54pp
2021-12-31	69.77%	Skr1.48 Billion ≈ $159.78 Million	Skr2.13 Billion ≈ $229.01 Million	-6.95pp
2020-12-31	76.72%	Skr1.47 Billion ≈ $157.97 Million	Skr1.91 Billion ≈ $205.90 Million	+43.86pp
2019-12-31	32.86%	Skr218.81 Million ≈ $23.55 Million	Skr665.90 Million ≈ $71.66 Million	-11.05pp
2018-12-31	43.91%	Skr289.79 Million ≈ $31.19 Million	Skr659.97 Million ≈ $71.02 Million	-10.05pp
2017-12-31	53.96%	Skr310.86 Million ≈ $33.45 Million	Skr576.11 Million ≈ $62.00 Million	+4.25pp
2016-12-31	49.71%	Skr243.08 Million ≈ $26.16 Million	Skr488.98 Million ≈ $52.62 Million	+49.71pp
2015-12-31	0.00%	Skr13.00K ≈ $1.40K	Skr473.18 Million ≈ $50.92 Million	0.00pp
2014-12-31	0.00%	Skr13.00K ≈ $1.40K	Skr415.61 Million ≈ $44.73 Million	-0.02pp
2013-12-31	0.02%	Skr80.00K ≈ $8.61K	Skr383.42 Million ≈ $41.26 Million	+0.01pp
2012-12-31	0.02%	Skr80.00K ≈ $8.61K	Skr517.02 Million ≈ $55.64 Million	-0.01pp
2011-12-31	0.03%	Skr80.00K ≈ $8.61K	Skr279.83 Million ≈ $30.11 Million	-0.01pp
2010-12-31	0.04%	Skr80.00K ≈ $8.61K	Skr227.82 Million ≈ $24.52 Million	-0.01pp
2009-12-31	0.04%	Skr80.00K ≈ $8.61K	Skr179.81 Million ≈ $19.35 Million	-0.52pp
2007-12-31	0.56%	Skr620.00K ≈ $66.72K	Skr110.77 Million ≈ $11.92 Million	-0.35pp
2006-12-31	0.91%	Skr830.00K ≈ $89.32K	Skr90.76 Million ≈ $9.77 Million	--

pp = percentage points

About BioGaia AB (publ)

ST:BIOG-B Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$1.17 Billion

Skr10.83 Billion SEK

Market Cap Rank

#8273 Global

#128 in Sweden

Share Price

Skr110.00

Change (1 day)

+1.76%

52-Week Range

Skr96.80 - Skr134.90

All Time High

Skr427.58